COVID-19 rapid test national shortage mobilizes White House, leaves experts cautiously optimistic

319
SHARES
2.5k
VIEWS

You Might Also Like


– Advertisement –


Coronavirus rapid tests are in short supply due to increasing demand from employers

– Advertisement –

Last week’s White House report reiterated President Biden’s employer order that businesses with 100 or more employees require every employee to be fully vaccinated or tested weekly for COVID-19. NS Need Affects more than 80 million workers in private Area.

White House COVID-19 response coordinator Jeffrey Ziants summarized in last week’s press talks That, “we are on track to quadruple the supply of rapid, at-home tests available to Americans to more than 200 million a month by December and to increase the number of locations where Americans live in the United States to 30,000 communities.” You can use the free trial-based location.”

advertisement

He emphasized the president’s firm commitment to adding an additional $1 billion to the already made $2 billion investment to increase supply.

– Advertisement –

Coronavirus in the US: State-by-state analysis

The two manufacturers, Quidel and OraSure, will further expand their rapid testing production capabilities, which is expected to increase to tens of millions of tests per month.

“Employer demand has been insane,” Quidl chief executive Doug Bryant recently told Reuters, noting that until last week the company was unable to meet all employer requests.

Food and Drug Administration (FDA) approved a new rapid at-home test manufactured by ACON Laboratories known as Flowflex, further accelerating the availability of at-home testing. Ziants considered the test to be the most affordable on the market, estimating that the kit would retail for about $10 per test.

He added that large government purchases of these in-house tests should bring down the cost. In addition, the White House worked with Amazon, Kroger and Walmart to sell rapid test kits at a price for the next several months.

Bidding wars between health systems and states have so far received high price points in the US, according to Reuters.

President of the COVID-19 Scientific Safety Review Workgroup in California and division head of epidemiology at UC Berkeley, Dr. Arthur Reingold cautioned in an email to Granthshala News: “The US lags behind many other wealthy countries in making reliable COVID-19 tests, especially rapid tests, widely available.”

Why are some countries recommending a single coronavirus vaccine dose for teenagers, young adults?

While European countries continued to buy rapid test kits in May, Abbott Labs, one of the most popular rapid testing kits known as Binex Now, began laying off staff and increasing its surplus around that time. Decided to exclude expired components. this is news.

On October 5, FDA issued The alert detailing the recall of COVID-19 rapid testing kits manufactured by Australian-based company Alum after some tests discovered that COVID-19 resulted in a higher-than-expected false-positive rate. A false positive result means that the patient has been diagnosed with an infection that he or she does not actually have.

However, the director of the FDA’s Center for Devices and Radiological Health, Dr. Jeffrey E. Shuren wrote in a press statement earlier this month that at-home COVID-19 testing is a high priority for the FDA to review.

Reingold said, “The announcement that the Biden administration is directing more funding to make rapid tests more widely available is very welcome news. The results of such tests can facilitate the decisions of individuals and families.” Schools and workplaces; and from long-term everything from restaurants to sports clubs to spectator events and concerts have facilitated the safe return of activities that everyone is eager to resume. ”

White House last week doubledThe federal government’s free testing program outnumbers local pharmacies, so there are about 30,000 sites available to access a free COVID-19 rapid test.

Large pharmacy chains are getting active to meet the growing demand.Joseph Goode, senior director of corporate communications at CVS, told Granthshala News: “We have been able to meet the demand for COVID-19 testing in most locations, even with the increasing number of patients seeking testing. Also, CVS stores across the country provide several over-the-counter COVID-19 test kits, allowing patients to self-test at home.”

Click to get Granthshala News App

In response to high demand, CVS introduced product ranges from Abbott’s Binex Now and Quidl trials, but Goode noted that CVS is committed to working with suppliers to meet customer demand.


– Advertisement –

Related News

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending News